Satraplatin in the treatment of hormone-refractory prostate cancer

被引：27
作者：
Sternberg, CN
机构：
[1] San Camillo Hosp, Dept Med Oncol, I-00152 Rome, Italy
[2] Forlanini Hosp, Dept Med Oncol, I-00152 Rome, Italy
来源：
BJU INTERNATIONAL | 2005年 / 96卷 / 07期
关键词：
D O I：
10.1111/j.1464-410X.2005.05799.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：990 / 994
页数：5
相关论文
共 22 条
  • [1] *AM CANC SOC, 2005, CANC FACTS FIG 2005, P12
  • [2] Combined effects of the orally active cisplatin analog, JM216, and radiation in antitumor therapy
    Amorino, GP
    Mohr, PJ
    Hercules, SK
    Pyo, H
    Choy, H
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 46 (05) : 423 - 426
  • [3] Novel therapeutic strategies for androgen-independent prostate cancer: An update
    Assikis, VJ
    Simons, JW
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (02) : 26 - 32
  • [4] Phase I study of oral JM216 given twice daily
    Beale, P
    Raynaud, F
    Hanwell, J
    Berry, C
    Moore, S
    Odell, D
    Judson, I
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (02) : 142 - 148
  • [5] EISENBERGER MA, 2004, P AM SOC CLIN ONCOL, V23
  • [6] KELLAND LR, 1993, CANCER RES, V53, P2581
  • [7] An update on satraplatin: the first orally available platinum anticancer drug
    Kelland, LR
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (06) : 1373 - 1382
  • [8] Pharmacokinetic and pharmacodynamic analysis of bis-acetato-ammine-dichloro-cyclohexylamine-platinum (JM216) administered once a day for five consecutive days: A phase I study
    Kurata, T
    Tamura, T
    Sasaki, Y
    Fujii, H
    Negoro, S
    Fukuoka, M
    Saijo, N
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2000, 30 (09) : 377 - 384
  • [9] A PHASE-I AND PHARMACOLOGY STUDY OF AN ORAL PLATINUM COMPLEX, JM216 - DOSE-DEPENDENT PHARMACOKINETICS WITH SINGLE-DOSE ADMINISTRATION
    MCKEAGE, MJ
    MISTRY, P
    WARD, J
    BOXALL, FE
    LOH, S
    ONEILL, C
    ELLIS, P
    KELLAND, LR
    MORGAN, SE
    MURRER, B
    SANTABARBARA, P
    HARRAP, KR
    JUDSON, IR
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 36 (06) : 451 - 458
  • [10] MCKEAGE MJ, 1994, CANCER RES, V54, P4118
123